B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, Élodie Bauer et al.|Annals of the Rheumatic Diseases|2021Cited by 20